Cardiff University has secured a share of a £150m government investment in the UK’s clinical research infrastructure.
Announcing the funding Chancellor George Osbourne confirmed that the £150m investment would be shared across 23 projects. Cardiff University will receive a £6.7m share along with the UK Dementias Research Platform (UKDP), which secured £36.8m. The UKDP is led by Dr John Gallacher at Cardiff University.
The Treasury has worked in partnership with the Department of Business, Innovation & Skills (BIS) to allocate the funding to the Medical Research Council’s (MRC) Clinical Research Capital Initiative.
It follows the £80m also pledged to the initiative by the MRC, universities, charities and devolved authorities, bringing the total amount of finance available to £230m. The investment will assist research in a range of revolutionary technologies aimed at identifying the causes of diseases such as cancer and dementia, and dramatically speeding up diagnosis and treatment. The state-of-the-art technologies will be used to find out how differences in the cellular and molecular make-up of people affect how they respond to diseases and to treatment.
“The UK is already a world leader in science and research, which is why at the Budget, I protected science spending, Today we go a step further by announcing £150m of new investment in clinical research infrastructure. The funding will go to 23 truly innovative projects from across the UK today that represent the best of British ingenuity and scientific exploration.” ” said Osborne.
To find out more of Cardiff University’s involvement in this initiative visit the Medical Research Council website.